These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31078550)

  • 21. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.
    Lefevre-Pettazzoni M; Bissery A; Wallon M; Cozon G; Peyron F; Rabilloud M
    Clin Vaccine Immunol; 2007 Mar; 14(3):239-43. PubMed ID: 17202303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
    Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
    J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
    Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
    Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of circulating antigens in the diagnosis of acute toxoplasmosis.
    Acebes MV; Diez B; Garcia-Rodriguez JA; Viens P; Cisterna R
    Am J Trop Med Hyg; 1994 Oct; 51(4):506-11. PubMed ID: 7943580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HIV aspartyl protease inhibitors on experimental infection with a cystogenic Me49 strain of
    Abou-El-Naga IF; Gomaa MM; ElAchy SN
    Pathog Glob Health; 2022 Mar; 116(2):107-118. PubMed ID: 34420500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
    Romand S; Della Bruna C; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraglandular toxoplasmosis of the parotid gland pre- or postoperative diagnosis?
    Hadi U; Rameh C
    Am J Otolaryngol; 2007; 28(3):201-4. PubMed ID: 17499141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral Abnormalities in a Mouse Model of Chronic Toxoplasmosis Are Associated with MAG1 Antibody Levels and Cyst Burden.
    Xiao J; Li Y; Prandovszky E; Kannan G; Viscidi RP; Pletnikov MV; Yolken RH
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004674. PubMed ID: 27124472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could miltefosine be used as a therapy for toxoplasmosis?
    Eissa MM; Barakat AM; Amer EI; Younis LK
    Exp Parasitol; 2015 Oct; 157():12-22. PubMed ID: 26112396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on the diagnosis and management of Toxoplasma gondii infection in cats.
    Lappin MR
    Top Companion Anim Med; 2010 Aug; 25(3):136-41. PubMed ID: 20937495
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS; El Naggar HM; Abdelmaksoud HF; Barakat AM; Abdelhameed RM; Shehata MAS
    Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
    Mitchell SM; Zajac AM; Davis WL; Lindsay DS
    J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis.
    McHugh TD; Bathgate T; Mangan J; Johnson JD; Holliman RE; Butcher PD
    J Med Microbiol; 1997 Jul; 46(7):587-95. PubMed ID: 9236743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: a novel strategy for prevention of human exposure to meat-borne toxoplasmosis.
    Kul O; Yildiz K; Ocal N; Freyre A; Deniz A; Karahan S; Atmaca HT; Gokpinar S; Dincel GC; Uzunalioğlu T; Terzi OS
    Res Vet Sci; 2013 Apr; 94(2):269-76. PubMed ID: 22954788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
    Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
    Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the therapeutics of experimental toxoplasmosis. II. Effect of acetylspiramycin alone or in combination with an immunopotentiator (CSP-II) or sulfamethopyrazine on Toxoplasma multiplication in the heart of mice acutely and chronically infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Takei Y; Sakurai H; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1982 Feb; 35(2):362-8. PubMed ID: 7087173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasmosis in wallabies (Macropus rufogriseus and Macropus eugenii): blindness, treatment with atovaquone, and isolation of Toxoplasma gondii.
    Dubey JP; Crutchley C
    J Parasitol; 2008 Aug; 94(4):929-33. PubMed ID: 18576797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.